Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The Food and Drug Administration declined approval of ViiV Healthcare’s injectable HIV regimen Cabenuva.
Amid talk of “ending HIV,” we must also focus on those with the virus, says Anthony S. Fauci, MD.
Pregnant women with HIV often don’t receive treatment per guidelines, according to a study of more than 1,800 HIV-positive pregnant women.
ViiV applies for FDA approval of HIV drug fostemsavir
April/May 2020 Survey
The retailer offers services such as routine checkups, eye and dental exams, and therapy and may expand nationwide.
Newer drug classes are tied to a higher risk of weight gain, which is more likely to occur among Black women in particular.
5 factors influencing the well-being of women with HIV
A new strawberry-flavored HIV med is a game changer for children living with HIV.
Gilead’s HIV capsid inhibitor might need dosing only every six months
Researchers are working on patches containing tiny needles that deliver medications through the skin.
Researchers at George Washington University take a look.
Expanded access study confirms the long-acting monoclonal antibody works well in people with extensive prior treatment.
A look at December issues from the POZ archives
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.